Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissue

被引:0
|
作者
Andrew G. Chambers
David C. Chain
Steve M. Sweet
Zifeng Song
Philip L. Martin
Matthew J. Ellis
Claire Rooney
Yeoun Jin Kim
机构
[1] AstraZeneca,Early Oncology
[2] AstraZeneca,Early Oncology
来源
Clinical Proteomics | 2023年 / 20卷
关键词
Mass spectrometry; Targeted proteomics; FFPE; Translational medicine; Target engagement;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRASG12C Inhibitor
    Lv, Yan
    Yang, Zixuan
    Chen, Yiming
    Ma, Xuepei
    Guo, Mengqi
    Zhang, Chengwei
    Jiang, Xiaolin
    Wang, Chengli
    Li, Zhuoyue
    Tai, Zhengfu
    Wang, Xiao
    Zhang, Siqi
    Ma, Shumin
    Qin, Chong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (04) : 2487 - 2511
  • [42] Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRASG12C
    Li, Amin
    Li, Sujing
    Wang, Peng
    Dang, Chaojie
    Fan, Xinrui
    Chen, Mengran
    Liu, Dan
    Li, Fu
    Liu, Huan
    Zhang, Wei
    Wang, Yanping
    Wang, Yinxiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 2422 - 2436
  • [43] Fit-for-Purpose Synthesis of a KRASG12C Covalent Inhibitor, via a Diastereoselective Hayashi Arylation
    Molinaro, Carmela
    Wong, Nicholas
    White, Nicholas A.
    Sirois, Lauren E.
    Bigler, Raphael
    Bindschaedler, Quentin P.
    Do, Steven
    Malhotra, Sushant
    Gosselin, Francis
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2024, 28 (08) : 3313 - 3325
  • [44] Probing and overcoming KRASG12C inhibitor resistance by combination with a pan-KRAS SOS1 inhibitor
    Hofmann, Marco H.
    Jurado, Sabine
    Gerlach, Daniel
    Koga, Takamasa
    Trapani, Francesca
    Gmachl, Michael
    Alpar, Donat
    Lieb, Simone
    Jeschko, Astrid
    Mitsudomi, Tetsuya
    Kraut, Norbert
    Petronczki, Mark P.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Identification of Candidate Alterations Mediating KRASG12C Inhibitor Resistance in Advanced Colorectal and Pancreatic Cancers
    Jazieh, Khalid
    Tsai, Jill
    Solomon, Sheila
    Zhu, Mojun
    Sinicrope, Frank A.
    Pedersen, Katrina S.
    Fernandez-Zapico, Martin E.
    Xie, Hao
    CLINICAL CANCER RESEARCH, 2025, 31 (05) : 899 - 906
  • [46] BPI-421286: A highly potent small molecule inhibitor targeting KRASG12C mutation
    Zhu, Xiaoguan
    Lu, Yuan
    Guo, Jing
    Yan, Dan
    Li, Boyan
    Chen, Xiaoping
    Chen, Haibo
    Lan, Hong
    Wu, Hao
    Ding, Lieming
    Wang, Jiabing
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRASG12C Inhibitor
    Douglas, James J.
    Tatton, Matthew R.
    de Bruin, Daniel
    Buttar, David
    Cook, Calum
    Dai, Kuangchu
    Ferrer, Catalina
    Leslie, Kevin
    Morrison, James
    Munday, Rachel
    Ronson, Thomas O.
    Zhao, Hucheng
    JOURNAL OF ORGANIC CHEMISTRY, 2022, 87 (04): : 2075 - 2086
  • [48] Synthesis of Adagrasib (MRTX849), a Covalent KRASG12C Inhibitor Drug for the Treatment of Cancer
    Chen, Cheng-yi
    Lu, Zhichao
    Scattolin, Thomas
    Chen, Chengsheng
    Gan, Yonghong
    McLaughlin, Mark
    ORGANIC LETTERS, 2023, : 944 - 949
  • [49] Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
    Ma, Xiaoshen
    Sloman, David L.
    Duggal, Ruchia
    Anderson, Kenneth D.
    Ballard, Jeanine E.
    Bharathan, Indu
    Brynczka, Christopher
    Gathiaka, Symon
    Henderson, Timothy J.
    Lyons, Thomas W.
    Miller, Richard
    Munsell, Erik V.
    Orth, Peter
    Otte, Ryan D.
    Palani, Anandan
    Rankic, Danica A.
    Robinson, Michelle R.
    Sather, Aaron C.
    Solban, Nicolas
    Song, Xuelei Sherry
    Wen, Xin
    Xu, Zangwei
    Yang, Yi
    Yang, Ruojing
    Day, Phil J.
    Stoeck, Alexander
    Bennett, David Jonathan
    Han, Yongxin
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (13) : 11024 - 11052
  • [50] SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling
    Fedele, Carmine
    Li, Shuai
    Teng, Kai Wen
    Foster, Connor J. R.
    Peng, David
    Ran, Hao
    Mita, Paolo
    Geer, Mitchell J.
    Hattori, Takamitsu
    Koide, Akiko
    Wang, Yubao
    Tang, Kwan Ho
    Leinwand, Joshua
    Wang, Wei
    Diskin, Brian
    Deng, Jiehui
    Chen, Ting
    Dolgalev, Igor
    Ozerdem, Ugur
    Miller, George
    Koide, Shohei
    Wong, Kwok-Kin
    Neel, Benjamin G.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (01):